New injection tested to shrink skin cancer before removal
NCT ID NCT05858229
Summary
This early-stage study is testing whether injecting an experimental therapy called RP1 directly into skin cancer tumors can help shrink them before surgical removal. The trial will enroll up to 12 adults with resectable cutaneous squamous cell carcinoma to assess safety and see if the treatment eliminates cancer cells in the tissue later removed during surgery. Researchers aim to understand if this approach could improve outcomes for patients facing skin cancer surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rochester Dermatologic Surgery
Victor, New York, 14564, United States
Conditions
Explore the condition pages connected to this study.